why choose us

First received: March 15, 2023

Clinical Trial: A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Mesonephric Gynecologic Cancer

Study Type: INTERVENTIONAL


Official Title: Single Arm Phase II Study of Avutometinib (VS-6766) and Defactinib in Advanced or Recurrent Mesonephric Gynecologic Cancer

Brief Summary: This study will test if Avutometinib (VS-6766) in combination with Defactinib is an effective treatment for advanced or recurrent mesonephric gynecologic cancer.

Read more